Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wang LF et al. – The results showed that the expression of the immunocasp–6 gene not only significantly prolonged animal's survival, but also greatly inhibited tumor metastasis. Thereby, strategy suggests an alternative approach to treating HER2/neu–positive osteosarcoma.

Related Articles

The role of interferons in the treatment of osteosarcoma
Pediatric Blood & Cancer, 11/12/09    Relevance Score: 88%

Reconstruction Using a Frozen Bone Method for Osteosarcoma of the Talus. A Case Report and Review of the Literature
Anticancer Research, 11/11/09    Relevance Score: 88%

Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways
British Journal of Cancer, 11/06/09    Relevance Score: 88%

Synchronous and metachronous skeletal osteosarcomas: The Norwegian Radium Hospital experience
Acta Oncologica, 10/26/09    Relevance Score: 88%

Tumoral Calcinosis Mimicking Recurrent Osteosarcoma
Radiology Case Reports, 10/23/09    Relevance Score: 88%

Today in Basic Science/Genetics...keeping you current

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: An institutional-based review
Journal of Clinical Oncology, 11/30/09

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 11/30/09

Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: A meta-analysis involving 46,281 subjects
Breast Cancer Research and Treatment, 11/30/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address